King Pfizer Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KING PFIZER, and what generic and branded alternatives to KING PFIZER drugs are available?
KING PFIZER has two approved drugs.
Drugs and US Patents for King Pfizer
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-001 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-002 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
King Pfizer | HUMATIN | paromomycin sulfate | CAPSULE;ORAL | 062310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-003 | Feb 27, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for King Pfizer
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-002 | Feb 27, 2007 | 5,061,722 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | 7,368,469 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-001 | Feb 27, 2007 | 5,061,722 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | 5,403,856 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-003 | Feb 27, 2007 | 5,403,856 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-003 | Feb 27, 2007 | 7,368,469 | ⤷ Sign Up |
King Pfizer | ALTACE | ramipril | TABLET;ORAL | 022021-004 | Feb 27, 2007 | 5,061,722 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.